Literature DB >> 30694981

Cerebral Blood Flow during Exercise in Heart Failure: Effect of Ventricular Assist Devices.

Kurt J Smith1,2, Ignacio M Suarez3, Anna Scheer3, Lauren C Chasland1, Hannah J Thomas1, Marilia A Correia4, Lawrence G Dembo5, Louise H Naylor1,5, Andrew J Maiorana3,5, Daniel J Green1.   

Abstract

INTRODUCTION: In healthy individuals, cerebral blood flow (CBF) increases during exercise, but few studies have compared changes in CBF during exercise in patients with heart failure (HF) to healthy controls (CTRL) or assessed the effects of left ventricular assist devices (LVAD). We hypothesized that subjects implanted with LVAD would exhibit impaired cerebrovascular responses to cycle exercise when compared with age- and sex-matched healthy CTRL subjects but would have enhanced responses relative to subjects with HF.
METHODS: Internal carotid artery (ICA) blood flow and intracranial middle (MCAv) and posterior cerebral (PCAv) artery velocities were measured continuously using Doppler ultrasound, alongside cardiorespiratory measures at rest and in response to an incremental submaximal cycle ergometer exercise protocol in nine LVAD participants (58 ± 15 yr, 87 ± 16 kg, 172 ± 8 cm, six females), nine age- and sex-matched subjects with HF (58 ± 8 yr, 84 ± 11 kg, 177 ± 6 cm), and nine CTRL (55 ± 14 yr, 74 ± 16 kg, 168 ± 10 cm).
RESULTS: At rest, ICA hemodynamics (velocity, shear rate, and flow) were greater in CTRL and LVAD than that in HF (P < 0.05). Higher MCAv (+5.52 ± 1.59 cm·s, P = 0.003) and PCAv (+5.82 ± 1.41 cm·s, P = 0.001) were also observed in LVAD subjects than healthy CTRL. During exercise, ICA flow increased at all workloads in CTRL, but not in HF or LVAD groups. MCAv increased from baseline in both HF and CTRL participants (P = 0.0001), but not in LVAD subjects. Nonetheless, CTRL and LVAD showed higher MCAv (P = 0.006) and PCAv (P < 0.0001) values throughout exercise than HF.
CONCLUSION: Our findings indicate that LVAD subjects exhibit higher CBF at rest and during exercise than matched HF participants but attenuated brain blood flows during exercise when compared with healthy subjects. CBF should be considered when designing exercise training interventions in patients with HF and LVAD.

Entities:  

Mesh:

Year:  2019        PMID: 30694981     DOI: 10.1249/MSS.0000000000001904

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Cerebral blood flow responses to exercise are enhanced in left ventricular assist device patients after an exercise rehabilitation program.

Authors:  Kurt J Smith; Ignacio Moreno-Suarez; Anna Scheer; Lawrence Dembo; Louise H Naylor; Andrew J Maiorana; Daniel J Green
Journal:  J Appl Physiol (1985)       Date:  2019-11-27

2.  ln silico simulation of the interaction among autoregulatory mechanisms regulating cerebral blood flow rate in the healthy and systolic heart failure conditions during exercise.

Authors:  Surhan Bozkurt; Umut Engin Ayten
Journal:  Med Biol Eng Comput       Date:  2022-05-04       Impact factor: 2.602

3.  Angiotensin converting enzyme inhibition improves cerebrovascular control during exercise in male rats with heart failure.

Authors:  Alec L E Butenas; Trenton D Colburn; Dryden R Baumfalk; Carl J Ade; K Sue Hageman; Steven W Copp; David C Poole; Timothy I Musch
Journal:  Respir Physiol Neurobiol       Date:  2021-01-06       Impact factor: 1.931

Review 4.  The Exercising Brain: An Overlooked Factor Limiting the Tolerance to Physical Exertion in Major Cardiorespiratory Diseases?

Authors:  Mathieu Marillier; Mathieu Gruet; Anne-Catherine Bernard; Samuel Verges; J Alberto Neder
Journal:  Front Hum Neurosci       Date:  2022-01-21       Impact factor: 3.169

5.  Feasibility of high-intensity interval training in patients with left ventricular assist devices: a pilot study.

Authors:  Miguel Alvarez Villela; Thiru Chinnadurai; Kalil Salkey; Andrea Furlani; Mounica Yanamandala; Sasha Vukelic; Daniel B Sims; Jooyoung J Shin; Omar Saeed; Ulrich P Jorde; Snehal R Patel
Journal:  ESC Heart Fail       Date:  2020-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.